KeraNetics
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 E 1st St Ste 102, Winston Salem, Nor...Phone Number
(336) 725-0621Website
www.keranetics.comRevenue
<$5 MillionIndustry
About KeraNetics
KeraNetics, Inc. specializes in developing innovative products for managing radiation dermatitis, particularly through their flagship product, KeraStat Cream. This FDA-cleared cream is designed to alleviate symptoms associated with radiation therapy, such as redness, soreness, and skin irritation. The company primarily serves cancer patients undergoing radiotherapy, as well as healthcare providers who support these patients. Founded in partnership with the Wake Forest Institute for Regenerative Medicine, KeraNetics aims to improve the quality of life for individuals affected by radiation injuries.Explore more
KeraNetics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to KeraNetics
Compare insights from companies similar to KeraNetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
KeraNetics Tech Stack
A closer look at the technologies used by KeraNetics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding KeraNetics
Sign Up For FreeTo access detailed company insights
KeraNetics, Inc. specializes in developing innovative products for managing radiation dermatitis, particularly through their flagship product, KeraStat Cream. This FDA-cleared cream is designed to alleviate symptoms associated with radiation therapy, such as redness, soreness, and skin irritation. The company primarily serves cancer patients underg... Read More
